JP2017178789A - Oil-in-water type emulsified composition - Google Patents
Oil-in-water type emulsified composition Download PDFInfo
- Publication number
- JP2017178789A JP2017178789A JP2016063476A JP2016063476A JP2017178789A JP 2017178789 A JP2017178789 A JP 2017178789A JP 2016063476 A JP2016063476 A JP 2016063476A JP 2016063476 A JP2016063476 A JP 2016063476A JP 2017178789 A JP2017178789 A JP 2017178789A
- Authority
- JP
- Japan
- Prior art keywords
- oil
- component
- iob
- water
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 30
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims abstract description 36
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 27
- 235000005152 nicotinamide Nutrition 0.000 claims abstract description 18
- 239000011570 nicotinamide Substances 0.000 claims abstract description 17
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 17
- 239000007788 liquid Substances 0.000 claims abstract description 9
- 239000007764 o/w emulsion Substances 0.000 claims description 28
- 229960003966 nicotinamide Drugs 0.000 claims description 15
- 239000002537 cosmetic Substances 0.000 claims description 12
- 235000011187 glycerol Nutrition 0.000 claims description 12
- 150000002148 esters Chemical class 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000000194 fatty acid Substances 0.000 abstract description 9
- 230000007794 irritation Effects 0.000 description 32
- 230000000694 effects Effects 0.000 description 18
- 238000011156 evaluation Methods 0.000 description 16
- 238000000034 method Methods 0.000 description 14
- 230000037394 skin elasticity Effects 0.000 description 13
- 230000037393 skin firmness Effects 0.000 description 10
- 239000006071 cream Substances 0.000 description 8
- 235000014113 dietary fatty acids Nutrition 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 8
- 229930195729 fatty acid Natural products 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- -1 phosphate ester Chemical class 0.000 description 8
- 230000000638 stimulation Effects 0.000 description 8
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 6
- 238000004945 emulsification Methods 0.000 description 6
- 150000004665 fatty acids Chemical class 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 6
- 238000007665 sagging Methods 0.000 description 6
- 230000037303 wrinkles Effects 0.000 description 6
- 238000009472 formulation Methods 0.000 description 5
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 210000004209 hair Anatomy 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 230000004660 morphological change Effects 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 230000001603 reducing effect Effects 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 229940082500 cetostearyl alcohol Drugs 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 229960000735 docosanol Drugs 0.000 description 3
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 3
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- JSOVGYMVTPPEND-UHFFFAOYSA-N 16-methylheptadecyl 2,2-dimethylpropanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)C(C)(C)C JSOVGYMVTPPEND-UHFFFAOYSA-N 0.000 description 2
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 2
- SGPMPZKXUXPIBJ-UHFFFAOYSA-N C(C)C(CCCCC(=O)OCC(O)CO)(CC)CC Chemical compound C(C)C(CCCCC(=O)OCC(O)CO)(CC)CC SGPMPZKXUXPIBJ-UHFFFAOYSA-N 0.000 description 2
- LKUNXBRZDFMZOK-GFCCVEGCSA-N Capric acid monoglyceride Natural products CCCCCCCCCC(=O)OC[C@H](O)CO LKUNXBRZDFMZOK-GFCCVEGCSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940087068 glyceryl caprylate Drugs 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940100554 isononyl isononanoate Drugs 0.000 description 2
- 229940093629 isopropyl isostearate Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 2
- LKUNXBRZDFMZOK-UHFFFAOYSA-N rac-1-monodecanoylglycerol Chemical compound CCCCCCCCCC(=O)OCC(O)CO LKUNXBRZDFMZOK-UHFFFAOYSA-N 0.000 description 2
- ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- QHZLMUACJMDIAE-SFHVURJKSA-N 1-hexadecanoyl-sn-glycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)CO QHZLMUACJMDIAE-SFHVURJKSA-N 0.000 description 1
- OVYMWJFNQQOJBU-UHFFFAOYSA-N 1-octanoyloxypropan-2-yl octanoate Chemical compound CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC OVYMWJFNQQOJBU-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 1
- QOOJEEZYYXGPAO-UHFFFAOYSA-N 2,2-bis(2-ethylhexanoyloxymethyl)butyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(CC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC QOOJEEZYYXGPAO-UHFFFAOYSA-N 0.000 description 1
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 1
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 1
- FUWVMBCPMRAWPG-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-hydroxyoctadecanoate Chemical compound CCCCCCCCCCCCCCCCC(O)C(=O)OCC(O)CO FUWVMBCPMRAWPG-UHFFFAOYSA-N 0.000 description 1
- RRZWKUGIZRDCPB-UHFFFAOYSA-N 2,3-dihydroxypropyl hexanoate Chemical compound CCCCCC(=O)OCC(O)CO RRZWKUGIZRDCPB-UHFFFAOYSA-N 0.000 description 1
- BYPJBHDBVGRMOF-UHFFFAOYSA-N 2,3-dihydroxypropyl nonanoate Chemical compound CCCCCCCCC(=O)OCC(O)CO BYPJBHDBVGRMOF-UHFFFAOYSA-N 0.000 description 1
- INEPAWKRVXYLTC-UHFFFAOYSA-N 2,3-dihydroxypropyl undecanoate Chemical compound CCCCCCCCCCC(=O)OCC(O)CO INEPAWKRVXYLTC-UHFFFAOYSA-N 0.000 description 1
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 1
- NFIHXTUNNGIYRF-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCC NFIHXTUNNGIYRF-UHFFFAOYSA-N 0.000 description 1
- OUCGJMIVSYHBEC-UHFFFAOYSA-N 2-ethylhexyl 2-ethylhexanoate Chemical compound CCCCC(CC)COC(=O)C(CC)CCCC OUCGJMIVSYHBEC-UHFFFAOYSA-N 0.000 description 1
- LCVHZNSIAYNAGX-UHFFFAOYSA-N 2-ethylhexyl 3,5,5-trimethylhexanoate Chemical compound CCCCC(CC)COC(=O)CC(C)CC(C)(C)C LCVHZNSIAYNAGX-UHFFFAOYSA-N 0.000 description 1
- VDHIEQOYPSVNIM-UHFFFAOYSA-N 2-hexyldecyl 2-ethylhexanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)C(CC)CCCC VDHIEQOYPSVNIM-UHFFFAOYSA-N 0.000 description 1
- PTPDZZWUOHQSLG-UHFFFAOYSA-N 2-octyldodecyl 2,2-dimethylpropanoate Chemical compound CCCCCCCCCCC(COC(=O)C(C)(C)C)CCCCCCCC PTPDZZWUOHQSLG-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- BRORPGSJXSLXKN-UHFFFAOYSA-N 6-methylheptyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCOC(=O)CC(C)CC(C)(C)C BRORPGSJXSLXKN-UHFFFAOYSA-N 0.000 description 1
- KGKQNDQDVZQTAG-UHFFFAOYSA-N 8-methylnonyl 2,2-dimethylpropanoate Chemical compound CC(C)CCCCCCCOC(=O)C(C)(C)C KGKQNDQDVZQTAG-UHFFFAOYSA-N 0.000 description 1
- HNDYULRADYGBDU-UHFFFAOYSA-N 8-methylnonyl benzoate Chemical compound CC(C)CCCCCCCOC(=O)C1=CC=CC=C1 HNDYULRADYGBDU-UHFFFAOYSA-N 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- IEZRNEGTKRQRFV-LFBNJJMOSA-N N-octadecanoyl-4-hydroxysphinganine Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC IEZRNEGTKRQRFV-LFBNJJMOSA-N 0.000 description 1
- KZTJQXAANJHSCE-OIDHKYIRSA-N N-octodecanoylsphinganine Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)CCCCCCCCCCCCCCC KZTJQXAANJHSCE-OIDHKYIRSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- QHZLMUACJMDIAE-UHFFFAOYSA-N Palmitic acid monoglyceride Natural products CCCCCCCCCCCCCCCC(=O)OCC(O)CO QHZLMUACJMDIAE-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- GORMSINSWZJIKL-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-dimethylpropyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(C)(C)COC(=O)C(CC)CCCC GORMSINSWZJIKL-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- WMNULTDOANGXRT-UHFFFAOYSA-N bis(2-ethylhexyl) butanedioate Chemical compound CCCCC(CC)COC(=O)CCC(=O)OCC(CC)CCCC WMNULTDOANGXRT-UHFFFAOYSA-N 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229940105984 diethylhexyl succinate Drugs 0.000 description 1
- SZLIWAKTUJFFNX-UHFFFAOYSA-N dihydrocitronellol benzoate Natural products CC(C)CCCC(C)CCOC(=O)C1=CC=CC=C1 SZLIWAKTUJFFNX-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 229940100549 ethylhexyl isononanoate Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 150000002327 glycerophospholipids Chemical class 0.000 description 1
- 229940068939 glyceryl monolaurate Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229940099578 hydrogenated soybean lecithin Drugs 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000007934 lip balm Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940048862 octyldodecyl neopentanoate Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 229940116422 propylene glycol dicaprate Drugs 0.000 description 1
- DCBSHORRWZKAKO-UHFFFAOYSA-N rac-1-monomyristoylglycerol Chemical compound CCCCCCCCCCCCCC(=O)OCC(O)CO DCBSHORRWZKAKO-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、肌のハリ・弾力を向上させ、かつ刺激感・べたつきがない使用感触に優れた水中油型乳化組成物に関するものである。 The present invention relates to an oil-in-water emulsified composition that improves the firmness and elasticity of the skin and is excellent in use feeling without irritation and stickiness.
皮膚は加齢やストレスなどの内的要因や、紫外線や空気の乾燥などの外的要因により、しみやシワ、たるみ、色素沈着等を生じる。中でもシワやたるみといった形態的変化は、外観の印象を大きく左右するため改善を望む人は多い。それらシワ・たるみを予防・改善するために多くの薬剤が提案されている。このような中でも、ニコチン酸アミドはビタミン類であって安全性が高く、皮膚老化防止効果を有することが知られている。(特許文献1)しかしながら例えばアトピー性皮膚炎等の特に感受性の高い皮膚に対しては刺激感を与える場合があるという課題があった。ニコチン酸アミドを配合した上で、刺激感を低減する試みに関して、一部報告はあるものの、効果は不十分であった。(特許文献2、特許文献3)。さらに、ニコチン酸アミドを多量に含有するとべたつきなど、望ましくない使用感触があることが知られており、この改善を行ってきた。(特許文献4) Skin causes spots, wrinkles, sagging, pigmentation and the like due to internal factors such as aging and stress and external factors such as ultraviolet rays and air drying. Among them, morphological changes such as wrinkles and sagging greatly affect the appearance impression, and many people want to improve it. Many drugs have been proposed to prevent and improve these wrinkles and sagging. Among these, nicotinic acid amides are vitamins and are known to have high safety and have an effect of preventing skin aging. However, there has been a problem that irritation may be given to particularly sensitive skin such as atopic dermatitis. Although some reports have been made regarding attempts to reduce irritation after compounding nicotinamide, the effect has been insufficient. (Patent Document 2, Patent Document 3). Furthermore, it has been known that when a large amount of nicotinamide is contained, there is an undesirable feeling of use such as stickiness, and this improvement has been made. (Patent Document 4)
しかしながら、刺激感を低減しようとした特許文献2の技術は、糖と水溶性の皮膜形成高分子を共に含有するため、よりべたつきが増し使用感触が悪いものであった。また、同じく刺激感の低減を試みた特許文献3は、ニコチン酸アミドの含有量が低い場合にのみ限定され、高含有の場合にはその効果は不十分であった。一方で、べたつきを押さえようとした特許文献4はN−アセルチルグルコサミン及び酸性ムコ多糖をを共に含有する技術であるが、効果は不十分であった。
However, since the technique of Patent Document 2 which attempts to reduce the feeling of irritation contains both a sugar and a water-soluble film-forming polymer, it is more sticky and has a poor feeling in use. Further, Patent Document 3 which tried to reduce the irritation is limited only when the content of nicotinamide is low, and the effect is insufficient when the content is high. On the other hand, although patent document 4 which tried to suppress stickiness is a technique which contains both N-acetylglucosamine and acidic mucopolysaccharide, the effect was inadequate.
すなわち、ニコチン酸アミドを高濃度で含有し、肌のハリ・弾力を向上させ、刺激感・べたつきがない使用感触に優れた化粧料は知られていない状況である。
That is, cosmetics that contain nicotinamide at a high concentration, improve the firmness and elasticity of the skin, and do not have irritation or stickiness are known.
かかる実情を鑑み、本発明者らは、上記課題を解決するために鋭意研究を重ねた結果、ニコチン酸アミドを3〜10質量%という高濃度で含有した場合においても、リン脂質、モノグリセリン脂肪酸エステル、および、25℃で液状であり、IOB値が0.10〜0.39である油を含有した場合に、ニコチン酸アミドによる使用時のべたつき、および、皮膚に対する刺激が低減されることを見出した。
In view of this situation, the present inventors have conducted extensive research to solve the above problems, and as a result, even when nicotinamide is contained at a high concentration of 3 to 10% by mass, phospholipids and monoglycerin fatty acids are obtained. When it contains an ester and an oil that is liquid at 25 ° C. and has an IOB value of 0.10 to 0.39, stickiness during use with nicotinamide and skin irritation are reduced. I found it.
さらに驚くべきことに、これらを組み合わせることにより、ニコチン酸アミド単体を含有するときよりも肌のハリ・弾力が向上することを見出し、シワ・たるみといった老化の形態的変化を予防・改善することを見出して本発明を完成した。
Surprisingly, by combining these, it was found that the firmness and elasticity of the skin was improved compared to the case of containing nicotinamide alone, and that morphological changes of aging such as wrinkles and sagging were prevented and improved. As a result, the present invention has been completed.
本発明の水中油型乳化組成物は、肌のハリ・弾力を向上させ、シワ・たるみといった老化の形態的変化を予防・改善すると共に、刺激感・べたつきがない使用感触に優れた効果を有するものである。
The oil-in-water emulsion composition of the present invention improves the firmness and elasticity of the skin, prevents and improves aging morphological changes such as wrinkles and sagging, and has an excellent effect on use feeling without irritation and stickiness Is.
以下、本発明について詳細に説明する。なお、本明細書において、「〜」はその前後の数値を含む範囲を意味するものとする。また、%で表記する数値は、特に記載した場合を除き、質量を基準にした値である。
Hereinafter, the present invention will be described in detail. In the present specification, “to” means a range including numerical values before and after. Moreover, the numerical value described in% is a value based on mass, unless otherwise specified.
成分(A):ニコチン酸アミド
本発明における成分(A)ニコチン酸アミドは、ニコチン酸(ビタミンB3/ナイアシン)のアミドである。ニコチン酸アミドは水溶性ビタミンで、ビタミンB群の一つである公知の物質であり、天然物(米ぬかなど)から抽出されたり、あるいは公知の方法によって合成することができる。具体的には、第15改正日本薬局方2008に収載されているものを用いることが出来る。
Component (A): Nicotinamide The component (A) nicotinamide in the present invention is an amide of nicotinic acid (vitamin B3 / niacin). Nicotinamide is a water-soluble vitamin and is a known substance that is one of the vitamin B groups, and can be extracted from a natural product (rice bran or the like) or synthesized by a known method. Specifically, those listed in the 15th revision Japanese Pharmacopoeia 2008 can be used.
本発明において成分(A)の量は、肌荒れや肌のハリ・弾力を向上させ、べたつきを抑えるためには3〜10%が好ましく4〜8%が特に好ましい。3%未満では肌のハリ・弾力を向上させる効果が不十分である。10%を超えても効果は上昇しない。
In the present invention, the amount of the component (A) is preferably 3 to 10%, particularly preferably 4 to 8%, in order to improve rough skin, firmness and elasticity of the skin, and to suppress stickiness. If it is less than 3%, the effect of improving the elasticity and elasticity of the skin is insufficient. Even if it exceeds 10%, the effect does not increase.
成分(B):リン脂質
本発明に用いる成分(B)のリン脂質は、構造中にリン酸エステル部位をもつ脂質を指す。リン脂質は、大きく分けてグリセリンを骨格とするグリセロリン脂質と、スフィンゴシンを骨格とするスフィンゴリン脂質の2つが存在するがいずれのものも好適に使用できる。
本発明に用いる成分(B)のリン脂質は、具体的には大豆や卵黄から抽出した大豆レシチン、卵黄レシチン及び/又はこれらを水素添加した水素添加大豆レシチン、水素添加卵黄レシチンや合成リン脂質など、一般にリン脂質として知られるものや、アシル化リン脂質、糖やポリエチレングリコールなどで修飾したリン脂質誘導体などが使用できる。
グリセリンと結合する脂肪酸が1本であるリゾリン脂質も使用可能である。
リン脂質としては、例えば、ホスファチジルコリン、ホスファチジルエタノールアミン、ホスファチジルグリセロール、ホスファチジルセリン、ホスファチジン酸、およびホスファチジルイノシトールなどが好ましく、これらを1種又は2種以上組み合わせて用いることができる。リン脂質を構成する脂肪酸としては、炭素数7〜22の飽和あるいは不飽和カルボン酸が挙げられる。
Component (B): Phospholipid The phospholipid of the component (B) used in the present invention refers to a lipid having a phosphate ester site in the structure. There are roughly two types of phospholipids, glycerophospholipids having glycerin as a skeleton and sphingophospholipids having sphingosine as a skeleton, and any of them can be preferably used.
The phospholipid of component (B) used in the present invention specifically includes soybean lecithin extracted from soybean and egg yolk, egg yolk lecithin and / or hydrogenated soybean lecithin hydrogenated with these, hydrogenated egg yolk lecithin, synthetic phospholipid, etc. Those generally known as phospholipids, acylated phospholipids, phospholipid derivatives modified with sugar or polyethylene glycol, and the like can be used.
A lysophospholipid having a single fatty acid binding to glycerin can also be used.
As the phospholipid, for example, phosphatidylcholine, phosphatidylethanolamine, phosphatidylglycerol, phosphatidylserine, phosphatidic acid, phosphatidylinositol and the like are preferable, and these can be used alone or in combination. Examples of the fatty acid constituting the phospholipid include saturated or unsaturated carboxylic acids having 7 to 22 carbon atoms.
本発明に係る水中油型乳化組成物の成分(B)の含有量は、0.1〜5質量%が好ましく0.5〜3%が特に好ましい。0.1%未満では刺激低減効果が不十分である。5%を超えても刺激低減効果は増強せず、べたつきが増す。この範囲であればべたつくことなく、刺激低減効果を有する上に水中油型乳化組成物の安定性にも優れている。
0.1-5 mass% is preferable and, as for content of the component (B) of the oil-in-water emulsion composition which concerns on this invention, 0.5-3% is especially preferable. If it is less than 0.1%, the stimulus reducing effect is insufficient. Even if it exceeds 5%, the irritation reduction effect is not enhanced and stickiness increases. If it is this range, it will not become sticky, and it has a stimulus reduction effect and is excellent in the stability of the oil-in-water emulsion composition.
成分(C): グリセリンモノ脂肪酸エステル
本発明で使用されるグリセリンモノ脂肪酸エステルは、グリセリンと脂肪酸とのモノエステルである。グリセリンモノ脂肪酸エステルは、脂肪酸とグリセリンのエステル化反応、または油脂および脂肪酸エステルとグリセリンとのエステル交換反応によって得られる。
Component (C): Glycerin monofatty acid ester The glycerin monofatty acid ester used in the present invention is a monoester of glycerin and a fatty acid. Glycerin monofatty acid ester is obtained by esterification reaction of fatty acid and glycerin, or transesterification reaction of fats and oils, fatty acid ester and glycerin.
本発明で使用されるグリセリンモノ脂肪酸エステルの原料となる脂肪酸としては、炭素数6〜22の直鎖または分岐の飽和または不飽和の脂肪酸が挙げられる。具体例としてはモノカプロン酸グリセリル、モノカプリル酸グリセリル、モノオクタン酸グリセリル、モノノナン酸グリセリル、モノカプリン酸グリセリル、モノウンデシレン酸グリセリル、モノラウリン酸グリセリル、モノミリスチン酸グリセリル、モノパルミチン酸グリセリル、モノステアリン酸グリセリル、モノイソステアリン酸グリセリル、モノオレイン酸グリセリル、モノヒドロキシステアリン酸グリセリル、モノモノベヘン酸グリセリルなどが挙げられるが、これに限定されるものではない。 Examples of the fatty acid used as a raw material for the glycerin monofatty acid ester used in the present invention include linear or branched saturated or unsaturated fatty acids having 6 to 22 carbon atoms. Specific examples include glyceryl monocaproate, glyceryl monocaprylate, glyceryl monooctanoate, glyceryl monononanoate, glyceryl monocaprate, glyceryl monoundecylate, glyceryl monolaurate, glyceryl monomyristate, glyceryl monopalmitate, glyceryl monostearate Glyceryl monoisostearate, glyceryl monooleate, glyceryl monohydroxystearate, glyceryl monomonobehenate, and the like, but are not limited thereto.
成分(C)の中でも炭素数が12〜22であると刺激低減効果に優れ好ましい。中でもモノステアリン酸グリセリルが刺激低減効果とともにべたつきを低減させる効果に優れ特に好ましい。一方、炭素数が6〜12のグリセリンモノ脂肪酸エステルは刺激低減効果を有するとともに水中油型乳化組成物の保存安定性に優れる。この効果はモノカプリン酸グリセリル、モノカプリル酸グリセリルが特に好ましい。これらを1種単独又は2種以上を組み合わせて用いることができる。
Among the components (C), the number of carbon atoms is preferably 12 to 22 for excellent stimulus reduction effect. Among them, glyceryl monostearate is particularly preferable because it is excellent in the effect of reducing the stickiness as well as the stimulus reducing effect. On the other hand, a glycerin monofatty acid ester having 6 to 12 carbon atoms has an effect of reducing irritation and is excellent in storage stability of an oil-in-water emulsion composition. This effect is particularly preferably glyceryl monocaprate and glyceryl monocaprylate. These can be used alone or in combination of two or more.
成分(C)の水中油型乳化組成物中における含有量は特に限定されないが、好ましくは0.1〜5質量%であり、より好ましくは0.15〜3質量%であり、さらに好ましくは0.2〜2質量%である。当該範囲内であれば、べたつくことなく刺激低減効果を有する上に、水中油型乳化組成物の保存安定性に優れるため好ましい。
The content of the component (C) in the oil-in-water emulsion composition is not particularly limited, but is preferably 0.1 to 5% by mass, more preferably 0.15 to 3% by mass, and still more preferably 0. .2 to 2% by mass. If it is in the said range, since it is excellent in the storage stability of an oil-in-water type emulsion composition while having the irritation | stimulation reduction effect without stickiness, it is preferable.
成分(D):25℃で液状であり、IOB値が0.10〜0.39である油
「液状」とは、1気圧下において、流動性を有している状態をいい、すなわち、融点以上の温度条件の下にある状態(融点を有さない非晶性物質においては溶融点以上の温度条件の下にある状態)をいう。なお、IOB値とは、有機概念図における有機性値(OV)に対する無機性値(IV)の比、すなわち「無機性値(IV)/有機性値(OV)」をいう。
IOB値が0.10未満の油では刺激低減効果がなく、べたつきが増す。一方0.39を超えると水中油型乳化組成物の保存安定性に劣り、刺激低減効果が不十分である。
Component (D): An oil “liquid” which is liquid at 25 ° C. and has an IOB value of 0.10 to 0.39 refers to a state having fluidity at 1 atmosphere, that is, a melting point The state under the above temperature condition (in the case of an amorphous substance having no melting point, the state under the temperature condition above the melting point). The IOB value refers to the ratio of the inorganic value (IV) to the organic value (OV) in the organic conceptual diagram, that is, “inorganic value (IV) / organic value (OV)”.
Oil with an IOB value of less than 0.10 has no irritation reduction effect and increases stickiness. On the other hand, when it exceeds 0.39, the storage stability of the oil-in-water emulsion composition is inferior, and the stimulus reduction effect is insufficient.
25℃で液状であり、IOB値が0.10〜0.39である油の具体的な例としては、2−エチルヘキサン酸セチル(IOB=0.13)、イソノナン酸イソトリデシル(IOB=0.15)、ジカプリン酸ネオペンチルグリコール(IOB=0.25)、ジカプリン酸プロピレングリコール(IOB=0.26)、リンゴ酸ジイソステアリル(IOB=0.28)、トリイソステアリン酸トリメチロールプロパン(IOB=0.16)、トリ−2−エチルヘキサン酸グリセリル(IOB=0.35)、ミリスチン酸イソプロピル(IOB=0.18)、イソノナン酸イソデシル(IOB=0.19)、ネオペンタン酸オクチルドデシル(IOB=0.13)、ネオペンタン酸イソステアリル(IOB=0.14)、パルミチン酸イソプロピル(IOB=0.16)、ラウリン酸ヘキシル(IOB=0.17)、エチルヘキサン酸ヘキシルデシル(IOB=0.13)、イソステアリン酸イソプロピル(IOB=0.15)、ジエチルヘキサン酸ネオペンチルグリコール(IOB=0.32)、トリエチルヘキサン酸トリメチロールプロパン(IOB=0.33)、テトラエチルヘキサン酸ペンタエリスリチル(IOB=0.35)、イソデシルベンゾエート(IOB=0.23)、ジカプリル酸プロピレングリコール(IOB=0.32)、イソノナン酸イソノニル(IOB=0.20)、イソノナン酸エチルヘキシル(IOB=0.20)、ネオペンタン酸イソデシル(IOB=0.22)、エチルヘキサン酸エチルヘキシル(IOB=0.20)、トリエチルヘキサン酸グリセリル(IOB=0.36)、コハク酸ジエチルヘキシル(IOB=0.32)、パラメトキシケイ皮酸2−エチルヘキシル(IOB値=0.28)等が挙げられるがこれに限定されるものではない。
これらは、必要に応じて1種又は2種以上用いることができる。
Specific examples of oils that are liquid at 25 ° C. and have an IOB value of 0.10 to 0.39 include cetyl 2-ethylhexanoate (IOB = 0.13), isotridecyl isononanoate (IOB = 0.0.3). 15), neopentyl glycol dicaprate (IOB = 0.25), propylene glycol dicaprate (IOB = 0.26), diisostearyl malate (IOB = 0.28), trimethylolpropane triisostearate (IOB = 0.16), glyceryl tri-2-ethylhexanoate (IOB = 0.35), isopropyl myristate (IOB = 0.18), isodecyl isononanoate (IOB = 0.19), octyldodecyl neopentanoate (IOB = 0.13), isostearyl neopentanoate (IOB = 0.14), isopropyl palmitate (IOB = 0.16), hexyl laurate (IOB = 0.17), hexyldecyl ethylhexanoate (IOB = 0.13), isopropyl isostearate (IOB = 0.15), neopentyl glycol diethylhexanoate ( IOB = 0.32), trimethylolpropane triethylhexanoate (IOB = 0.33), pentaerythrityl tetraethylhexanoate (IOB = 0.35), isodecylbenzoate (IOB = 0.23), propylene glycol dicaprylate (IOB = 0.32), isononyl isononanoate (IOB = 0.20), ethylhexyl isononanoate (IOB = 0.20), isodecyl neopentanoate (IOB = 0.22), ethylhexyl ethylhexanoate (IOB = 0.0). 20), glyceryl triethylhexanoate Examples include, but are not limited to, ril (IOB = 0.36), diethylhexyl succinate (IOB = 0.32), 2-methoxyhexyl paramethoxycinnamate (IOB value = 0.28), and the like. .
These may be used alone or in combination of two or more as required.
本発明の化粧料における成分(D)の含有量は、特に制限されないが0.1〜20%が好ましく、より好ましくは0.5〜10質量%であり、さらに好ましくは1〜5質量%である。当該範囲内であれば、優れた使用感、保存安定性が得られるとともに肌のハリ・弾力に優れる。
Although content in particular of the component (D) in the cosmetics of this invention is not restrict | limited, 0.1-20% is preferable, More preferably, it is 0.5-10 mass%, More preferably, it is 1-5 mass%. is there. Within this range, excellent usability and storage stability can be obtained, and skin firmness and elasticity are excellent.
発明に用いる成分(E)水は、水中油型乳化組成物とするために含有されるものであり、化粧料に一般に用いられるものであれば、特に制限されない。水の他にも精製水、温泉水、深層水、或いは植物の水蒸気蒸留水でもよく、必要に応じて1種または2種以上を適宜選択して用いることができる。また含有量は、特に限定されず、適宜、他の成分量に応じて含有することができるが、概ね30〜90%の範囲で用いることができる。
The component (E) water used in the invention is contained in order to obtain an oil-in-water emulsion composition, and is not particularly limited as long as it is generally used in cosmetics. In addition to water, purified water, hot spring water, deep water, or steam distilled water from plants may be used, and one or two or more kinds may be appropriately selected and used as necessary. Moreover, content is not specifically limited, Although it can contain suitably according to the amount of other components, it can be used in 30 to 90% of range in general.
本発明の水中油型乳化組成物は、上記成分(A)〜(E)を含有することにより、肌のハリ・弾力を向上させ、シワ・たるみといった老化の形態的変化を予防・改善すると共に、刺激感・べたつきがない使用感触に優れた水中油型乳化組成物にすることが可能となる。
The oil-in-water emulsion composition of the present invention contains the components (A) to (E), thereby improving the elasticity and elasticity of the skin and preventing and improving morphological changes in aging such as wrinkles and sagging. It becomes possible to make an oil-in-water emulsified composition excellent in use feeling without irritation and stickiness.
ここで、水中油型乳化組成物中における成分(A)と成分(B)及び成分(C)の含有量比(A)/((B)+(C))が0.1〜20であると、成分(A)の刺激が低減され好ましい。また、成分(A)と成分(C)および(D)の質量比(A)/((C)+(D))が0.1〜20であれば、水中油型乳化組成物のべたつきが低減され好ましい。さらに、(C)/(D)が0.01〜5の範囲内である場合、経時での製剤の安定性に特に優れる。
Here, the content ratio (A) / ((B) + (C)) of the component (A), the component (B), and the component (C) in the oil-in-water emulsion composition is 0.1 to 20. And the irritation | stimulation of a component (A) is reduced and it is preferable. Moreover, if the mass ratio (A) / ((C) + (D)) of the component (A) and the components (C) and (D) is 0.1 to 20, the oil-in-water emulsion composition is not sticky. Reduced and preferred. Furthermore, when (C) / (D) is in the range of 0.01 to 5, the stability of the preparation over time is particularly excellent.
本発明の水中油型乳化組成物の製造方法は、公知の乳化方法であれば特に限定されることなく製造可能である。具体的には、分散乳化法、転送乳化法、ゲル乳化法、転相温度乳化法等である。好ましいものを例示するならば、あらかじめ成分(A)、(E)を含む水性成分を調製しておき、これに成分(B)〜(D)の油性成分を添加混合して得られる分散乳化法を用いることで、経時安定性に優れた水中油型乳化組成物とすることができる。
The method for producing the oil-in-water emulsion composition of the present invention is not particularly limited as long as it is a known emulsion method. Specifically, a dispersion emulsification method, a transfer emulsification method, a gel emulsification method, a phase inversion temperature emulsification method, and the like. If a preferable thing is illustrated, the dispersion emulsification method obtained by preparing the aqueous component containing component (A) and (E) previously, and adding and mixing the oil-based component of component (B)-(D) to this By using this, it is possible to obtain an oil-in-water emulsion composition having excellent stability over time.
本発明の水中油型乳化組成物には、上記成分の他に、本発明の効果を妨げない範囲で通常の化粧料に含有される任意成分、すなわち、低級アルコールや多価アルコール、さらにそれら以外の水性成分、油剤、粉体、水溶性高分子、皮膜形成剤、成分(B)以外の界面活性剤、油溶性ゲル化剤、有機変性粘土鉱物、樹脂、着色剤、紫外線吸収剤、防腐剤、抗菌剤、香料、酸化防止剤、pH調整剤、キレート剤、美容成分等を含有することができる。
In the oil-in-water emulsion composition of the present invention, in addition to the above-mentioned components, optional components contained in ordinary cosmetics within the range that does not interfere with the effects of the present invention, that is, lower alcohols and polyhydric alcohols, and other than these Aqueous components, oils, powders, water-soluble polymers, film forming agents, surfactants other than component (B), oil-soluble gelling agents, organically modified clay minerals, resins, colorants, UV absorbers, preservatives , Antibacterial agents, perfumes, antioxidants, pH adjusters, chelating agents, cosmetic ingredients, and the like.
本発明の水中油型乳化組成物は、他の成分との併用により種々の剤型とすることもできる。具体的には、液状、ゲル状、ペースト状、クリーム状、固形状等、種々の剤型にて実施することができる。
The oil-in-water emulsion composition of the present invention can be made into various dosage forms by using in combination with other components. Specifically, it can be carried out in various dosage forms such as liquid, gel, paste, cream, and solid.
本発明の水中油型乳化組成物は、種々の用途の化粧料として利用できる。例えば、化粧水、乳液、クリーム、美容液、マッサージ料、パック料、ハンドクリーム、ボディローション、ボディクリーム、日焼け止めなどのスキンケア化粧料、ファンデーション、アイシャドウ、アイライナー、マスカラ、アイブロウ、コンシーラー、口紅、リップクリーム等の仕上げ用化粧料ヘアミスト、トリートメント、ヘアクリーム、等の頭髪用化粧料などを例示することができる。その使用方法は、手や指、コットンで使用する方法、不織布等に含浸させて使用する方法等が挙げられる。
The oil-in-water emulsion composition of the present invention can be used as a cosmetic for various applications. For example, skin lotion, milky lotion, cream, beauty essence, massage, pack, hand cream, body lotion, body cream, sunscreen and other skin care cosmetics, foundation, eye shadow, eyeliner, mascara, eyebrow, concealer, lipstick Examples thereof include cosmetics for finishing hair such as lip balm, cosmetics for hair such as hair mist, treatment, hair cream and the like. The usage method includes a method of using hands, fingers and cotton, a method of impregnating a nonwoven fabric and the like, and the like.
本発明の水中油型乳化組成物は、皮膚外用剤の用途としても利用可能である。例えば、外用液剤、外用ゲル剤、クリーム剤、軟膏剤、リニメント剤、ローション剤、ハップ剤、硬膏剤、噴霧剤、エアゾール剤等が挙げられる。またその使用方法は、前記した化粧料と同様に挙げることができる。
The oil-in-water emulsion composition of the present invention can also be used as a skin external preparation. For example, an external solution, an external gel, a cream, an ointment, a liniment, a lotion, a haptic, a plaster, a spray, an aerosol, and the like can be given. Moreover, the usage method can be mentioned similarly to the above-mentioned cosmetics.
本発明について以下に実施例を挙げてさらに詳述するが、本発明はこれによりなんら限定されるものではない。含有量は特記しない限り、その成分が含有される系に対する質量%で示す。 The present invention will be described in more detail with reference to the following examples, but the present invention is not limited thereto. Unless otherwise specified, the content is expressed in mass% with respect to the system containing the component.
予備実験
下記表1に示す処方の水中油型乳化乳液を調製した。
Preliminary experiment An oil-in-water emulsified emulsion having the formulation shown in Table 1 below was prepared.
処方1のようにニコチン酸アミドが少ないと十分な肌のハリ・弾力を得ることができなかった。十分な効果が得られるようにニコチン酸アミドの量を増やした場合(処方2)、リン脂質があっても刺激を感じる人がいた。刺激を感じなくなるまでリン脂質を増量した(処方3)ところ、べたつきが発生し感触的に許容できないものとなった。
If the amount of nicotinamide was small as in Formula 1, sufficient skin firmness and elasticity could not be obtained. When the amount of nicotinamide was increased so as to obtain a sufficient effect (Formulation 2), some people felt irritation even with phospholipids. When the amount of phospholipid was increased until no irritation was felt (Formulation 3), stickiness occurred and the feel became unacceptable.
実施例1 本発明品1〜7及び比較品1〜4:水中油型乳化乳液
下記表2に示す処方の水中油型乳化乳液を調製し、肌のハリ・弾力、べたつき、刺激感について下記の方法により評価した。その結果も併せて表2に示す。
Example 1 Products 1 to 7 of the present invention and Comparative products 1 to 4: Oil-in-water emulsified emulsions Oil-in-water emulsified emulsions having the formulations shown in Table 2 below are prepared, and the following are given regarding skin firmness / elasticity, stickiness and irritation. The method was evaluated. The results are also shown in Table 2.
(製造方法)
A:成分1〜6を70℃で均一に溶解混合する。
B:成分7〜8を70℃で均一に溶解混合する。
C:BにAを添加し70℃で乳化する。
D:Cに成分9〜14を添加混合した後、40℃まで冷却して水中油型乳化乳液を得た。
(Production method)
A: Components 1 to 6 are uniformly dissolved and mixed at 70 ° C.
B: Components 7 to 8 are uniformly dissolved and mixed at 70 ° C.
C: A is added to B and emulsified at 70 ° C.
D: Components 9 to 14 were added to C and mixed, and then cooled to 40 ° C. to obtain an oil-in-water emulsion.
(評価項目)
イ.肌のハリ・弾力
ロ.べたつき
ハ.刺激感
(Evaluation item)
A. Skin firmness and elasticity. Sticky c. Irritation
(評価方法)
[イ、ロについて(官能評価)]
20代〜40代の女性で官能評価の訓練を受け、一定の基準で評価が可能な専門パネルを10名選定した。各試料について専門パネルが皮膚に塗布した時に感じる、肌のハリ・弾力、べたつきを下記絶対評価にて5段階に評価し評点を付け、各試料ごとにパネル全員の評点合計から、その平均値を算出し、下記4段階判定基準により判定した。
(Evaluation method)
[About Lee and Roh (Sensory evaluation)]
Women in their 20s and 40s received sensory evaluation training and selected 10 professional panels that could be evaluated according to certain standards. For each sample, the skin's firmness, elasticity, and stickiness felt when applied to the skin by each panel are rated in the following 5 grades and given a score. For each sample, the average value is calculated from the total score of all the panels. Calculated and judged according to the following four-step criteria.
(イ.肌のハリ・弾力の評価)
絶対評価基準
(評点):(評価)
5点:非常に肌のハリ・弾力があると感じる
4点:肌のハリ・弾力があると感じる
3点:やや肌のハリ・弾力があると感じる
2点:あまり肌のハリ・弾力があると感じない
1点:肌のハリ・弾力があると感じない
4段階判定基準
(判定):(評点の平均点)
◎ :4点を超える :非常に良好
○ :3点を超える4点以下 :良好
△ :2点を超える3点以下 :やや不良
× :2点以下 :不良
(I. Evaluation of skin elasticity and elasticity)
Absolute Evaluation Criteria (Score): (Evaluation)
5 points: feels skin firmness / elasticity 4 points: feels skin elasticity / elasticity 3 points: feels somewhat skin elasticity / elasticity 2 points: feels skin firmness / elasticity 1 point: I do not feel that the skin is firm or elastic. 4 step criteria (Judgment): (Average score)
◎: More than 4 points: Very good ○: More than 3 points, 4 points or less: Good △: More than 2 points, 3 points or less: Slightly poor ×: 2 points or less: Bad
(ロ.べたつきの評価)
絶対評価基準
(評点):(評価)
5点:べたつきを感じない
4点:ほとんどべたつきを感じない
3点:ややべたつきを感じる
2点:べたつきを感じる
1点:非常にべたつきを感じる
4段階判定基準
(B. Evaluation of stickiness)
Absolute Evaluation Criteria (Score): (Evaluation)
5 points: no stickiness 4 points: almost no stickiness 3 points: slightly sticky 2 points: feels sticky 1 point: very sticky 4 criteria
(判定):(評点の平均点)
◎ :4点を超える :非常に良好
○ :3点を超える4点以下 :良好
△ :2点を超える3点以下 :やや不良
× :2点以下 :不良
(Judgment): (Average score)
◎: More than 4 points: Very good ○: More than 3 points, 4 points or less: Good △: More than 2 points, 3 points or less: Slightly poor ×: 2 points or less: Bad
(評価方法)
[ハについて(官能評価)]
本発明における「刺激感」とは塗布直後のぴりぴり・ちくちくとした感触(スティンギング)であり、他に通常、紅斑や浮腫のような炎症性症状は伴わず、一過性に消失する反応を指すものである。事前に社内スティンギングテストを行い、刺激に感度が高く、安定した評価が可能な20代〜50代の男性10名を専門パネルとして選定した。各試料について専門パネルが皮膚に塗布した時に感じる、刺激感を下記絶対評価にて5段階に評価し評点を付け、各試料ごとにパネル全員の評点合計から、その平均値を算出し、下記4段階判定基準により判定した。
(Evaluation method)
[About Ha (sensory evaluation)]
The “stimulation” in the present invention is a crispness and tingling sensation (stinging) immediately after application, and usually has a reaction that disappears transiently without inflammatory symptoms such as erythema or edema. It is what you point to. An in-house sting test was conducted in advance, and 10 men in their 20s to 50s who were highly sensitive to stimuli and capable of stable evaluation were selected as specialized panels. For each sample, the irritation sensation felt when applied to the skin by the specialized panel was rated in the following 5 absolute ratings, given a score, and the average value was calculated from the total score of all panel members for each sample. Judgment was made based on the stage judgment criteria.
(刺激感の評価)
絶対評価基準
(評点):(評価)
5点:刺激を感じない
4点:ほとんど刺激を感じない
3点:やや刺激を感じる
2点:刺激を感じる
1点:はっきりと刺激を感じる
4段階判定基準
(判定):(評点の平均点)
◎ :4点を超える :刺激感はない
○ :3点を超える4点以下 :ほぼ刺激感はない
△ :2点を超える3点以下 :一般人ならばほぼ刺激を感じない
× :2点以下 :一般人でも刺激を感じる可能性あり
(Evaluation of irritation)
Absolute Evaluation Criteria (Score): (Evaluation)
5 points: No stimulation 4 points: Almost no stimulation 3 points: Slight stimulation 2 points: I feel stimulation 1 point: I feel a clear stimulus 4-step criteria (Judgment): (Average score)
◎: More than 4 points: No irritation ○: More than 3 points, 4 points or less: Almost no irritation △: More than 2 points, 3 points or less: General people hardly feel irritation ×: 2 points or less: Even ordinary people may feel irritation
表2の結果から明らかなように、本発明品1〜7の水中油型乳化乳液は、比較品1〜4の水中油型乳化乳液に比べ、肌のハリ・弾力、刺激感、べたつきの全てにおいて優れたものであった。
これに対して成分(C)を配合しない比較品1では刺激感を低減できなかった。また、成分(C)の代わりに他の脂肪酸エステルを含有した比較品では刺激感を低減できず、べたつきも増す傾向にあった。
As is clear from the results in Table 2, the oil-in-water emulsions of the inventive products 1 to 7 are all of the firmness / elasticity, irritation, and stickiness of the skin compared to the oil-in-water emulsions of the comparative products 1 to 4. It was excellent.
On the other hand, the comparative product 1 in which the component (C) was not blended could not reduce irritation. Moreover, in the comparative product containing other fatty acid ester instead of the component (C), the irritation sensation cannot be reduced and the stickiness tends to increase.
実施例2
本発明品8〜15及び比較品5〜8水中油型乳化乳液
下記表3に示す処方の水中油型乳化乳液を調製し、肌のハリ・弾力、べたつき、刺激感について上述の方法により評価した。その結果も併せて表3に示す。
なお、成分の後に示した数字はIOB値である。
Example 2
Invention products 8 to 15 and comparative products 5 to 8 oil-in-water emulsion emulsions Oil-in-water emulsion emulsions having the formulations shown in Table 3 below were prepared and evaluated for the firmness, elasticity, stickiness, and irritation of the skin by the above-described methods. . The results are also shown in Table 3.
The numbers after the components are IOB values.
(製造方法)
A:成分1〜11を70℃で均一に溶解混合する。
B:成分12〜14を70℃で均一に溶解混合する。
C:BにAを添加し70℃で乳化する。
D:Cに成分15〜20を添加混合した後、40℃まで冷却して水中油型乳化乳液を得た。
(Production method)
A: Components 1 to 11 are uniformly dissolved and mixed at 70 ° C.
B: Components 12 to 14 are uniformly dissolved and mixed at 70 ° C.
C: A is added to B and emulsified at 70 ° C.
D: Components 15 to 20 were added to C and mixed, and then cooled to 40 ° C. to obtain an oil-in-water emulsion.
表3の結果から明らかなように、本発明品の水中油型乳化乳液は、比較品の水中油型乳化乳液に比べ、肌のハリ・弾力、刺激感、べたつきの全てにおいて優れたものであった。
これに対して成分(D)の代わりにIOB値が範囲外の油剤を配合しても刺激感は低減しなかった。また、IOB値が範囲内であっても固体であるコレステロールではべたつきが改善しなかった。
As is apparent from the results in Table 3, the oil-in-water emulsion of the product of the present invention was superior in all of the firmness / elasticity, irritation, and stickiness of the skin compared to the oil-in-water emulsion of the comparative product. It was.
On the other hand, irritation | stimulation was not reduced even if it mix | blended the oil agent whose IOB value was out of the range instead of a component (D). Further, even when the IOB value was within the range, the solid cholesterol did not improve the stickiness.
実施例4:水中油型乳化クリーム
(成分) (質量%)
1.1,3−ブチレングリコール 12.0
2.グリセリン 5.0
3.精製水 残量
4.ニコチン酸アミド 5.0
5.リン脂質 0.5
6.リゾリン脂質 0.5
7.トリイソステアリン酸トリメチロールプロパン(IOB=0.16)
1.0
8.イソノナン酸イソノニル(IOB=0.20) 1.0
9.N−ステアロイルジヒドロスフィンゴシン 0.1
10.アスタキサンチン 0.001
11.トコフェロール 0.01
12.セトステアリルアルコール 2.0
13.ベヘニルアルコール 1.0
14.グリセリンモノイソステアリン酸エステル 1.0
15.パラオキシ安息香酸メチル 適量
16.アクリル酸・メタクリル酸アルキル共重合体 (注1) 0.15
17.キサンタンガム 0.1
18.水酸化ナトリウム2%溶液 0.2
19.香料 適量
注1:CARBOPOL 1382(LUBRIZOL ADVANCED MATERIALS 社製)
Example 4: Oil-in-water emulsified cream (component) (mass%)
1.1,3-Butylene glycol 12.0
2. Glycerin 5.0
3. Purified water remaining amount 4. Nicotinamide 5.0
5). Phospholipid 0.5
6). Lysophospholipid 0.5
7). Trimethylolpropane triisostearate (IOB = 0.16)
1.0
8). Isononyl isononanoate (IOB = 0.20) 1.0
9. N-stearoyl dihydrosphingosine 0.1
10. Astaxanthin 0.001
11. Tocopherol 0.01
12 Cetostearyl alcohol 2.0
13. Behenyl alcohol 1.0
14 Glycerin monoisostearate 1.0
15. Methyl paraoxybenzoate appropriate amount 16. Acrylic acid / alkyl methacrylate copolymer (Note 1) 0.15
17. Xanthan gum 0.1
18. Sodium hydroxide 2% solution 0.2
19. Perfume appropriate amount Note 1: CARBOPOL 1382 (manufactured by LUBRIZOL ADVANCED MATERIALS)
(製造方法)
A:成分1〜4を70℃で均一に溶解混合する。
B:成分5〜15を80℃で均一に溶解混合する。
C:AにBを添加し70℃で乳化する。
D:Cに成分16〜19を添加混合した後、40℃まで冷却して水中油型乳化クリームを得た。
(Production method)
A: Components 1 to 4 are uniformly dissolved and mixed at 70 ° C.
B: Components 5 to 15 are uniformly dissolved and mixed at 80 ° C.
C: B is added to A and emulsified at 70 ° C.
D: Components 16 to 19 were added to C and mixed, and then cooled to 40 ° C. to obtain an oil-in-water emulsified cream.
実施例4の水中油型乳化クリームは、肌のハリ・弾力、刺激感、べたつきのなさ、の全てにおいて優れたものであった。
The oil-in-water emulsified cream of Example 4 was excellent in all of skin firmness / elasticity, irritation, and non-stickiness.
実施例5:水中油型化粧下地
(成分) (質量%)
1.1,3−ブチレングリコール 7.0
2.ジプロピレングリコール 5.0
3.トリエタノールアミン 0.4
4.精製水 残量
5.ニコチン酸アミド 4.0
6.リン脂質 0.4
7.ステアリン酸 1.0
8.ポリオキシエチレン硬化ヒマシ油(注2) 0.2
9.ポリソルベート80 0.1
10.イソステアリン酸イソプロピル(IOB=0.15) 1.0
11.トリエチルヘキサン酸グリセリル(IOB=0.36) 1.0
12.セトステアリルアルコール 0.3
13.ベヘニルアルコール 0.5
14.グリセリンモノカプリル酸エステル 0.3
15.アクリル酸・メタクリル酸アルキル共重合体 0.3
16.キサンタンガム 0.1
17.タルク 0.4
18.含水シリカ 0.1
19.マイカ 1.3
20.酸化チタン 6.0
21.酸化鉄 0.1
注2:HCO-20(日本サーファクタント工業社製)
Example 5: Oil-in-water makeup base
(Ingredient) (mass%)
1.1,3-Butylene glycol 7.0
2. Dipropylene glycol 5.0
3. Triethanolamine 0.4
4). 4. Purified water remaining amount Nicotinamide 4.0
6). Phospholipid 0.4
7). Stearic acid 1.0
8). Polyoxyethylene hydrogenated castor oil (Note 2) 0.2
9. Polysorbate 80 0.1
10. Isopropyl isostearate (IOB = 0.15) 1.0
11. Glyceryl triethylhexanoate (IOB = 0.36) 1.0
12 Cetostearyl alcohol 0.3
13. Behenyl alcohol 0.5
14 Glycerin monocaprylate 0.3
15. Acrylic acid / alkyl methacrylate copolymer 0.3
16. Xanthan gum 0.1
17. Talc 0.4
18. Hydrous silica 0.1
19. Mica 1.3
20. Titanium oxide 6.0
21. Iron oxide 0.1
Note 2: HCO-20 (Nippon Surfactant Kogyo Co., Ltd.)
(製造方法)
A:成分15〜21を均一に分散する。
B:成分1〜5を70℃で均一に溶解し、Aを加え均一に混合する。
C:成分6〜14を80℃で均一に溶解混合する。
D:BにCを添加し70℃で乳化する。
E:Dを40℃まで冷却して水中油型化粧下地を得た。
(Production method)
A: Components 15 to 21 are uniformly dispersed.
B: Components 1 to 5 are uniformly dissolved at 70 ° C., and A is added and mixed uniformly.
C: Components 6 to 14 are uniformly dissolved and mixed at 80 ° C.
D: C is added to B and emulsified at 70 ° C.
E: D was cooled to 40 ° C. to obtain an oil-in-water makeup base.
実施例5の水中油型化粧下地は、肌のハリ・弾力、刺激感、べたつきのなさの全てにおいて優れたものであった。
The oil-in-water type makeup base of Example 5 was excellent in all of skin firmness / elasticity, irritation, and non-stickiness.
実施例6:水中油型乳化美容液
(成分) (%)
1.1,3−ブチレングリコール 5.0
2.プロピレングリコール 5.0
3.精製水 残量
4.ニコチン酸アミド 8.0
5.テトラエチルヘキサン酸ペンタエリスリチル(IOB=0.35) 0.25
6.ネオペンタン酸イソステアリル(IOB=0.14) 0.15
7.N−ステアロイルフィトスフィンゴシン 0.1
8.酢酸トコフェロール 0.01
9.セトステアリルアルコール 0.5
10.ベヘニルアルコール 0.6
11.グリセリンモノオレイン酸エステル 0.4
12.グリセリンモノカプリン酸エステル 0.1
13.カルボマー (注3) 0.15
14.(アクリル酸Na/アクリロイルジメチルタウリンNa)コポリマー
(注4) 0.1
15.水酸化ナトリウム2%溶液 0.2
16.エタノール 5.0
17.ヒアルロン酸ナトリウム 0.01
18.加水分解ヒアルロン酸 0.01
19.加水分解コラーゲン 0.01
20.香料 適量
注3:CARBOPOL 980(LUBRIZOL ADVANCED MATERIALS 社製)
注4:SIMULGEL EG(SEPIC社製)
Example 6: Oil-in-water emulsified serum
(Ingredient) (%)
1.1,3-Butylene glycol 5.0
2. Propylene glycol 5.0
3. Purified water remaining amount 4. Nicotinamide 8.0
5). Pentaerythrityl tetraethylhexanoate (IOB = 0.35) 0.25
6). Isostearyl neopentanoate (IOB = 0.14) 0.15
7). N-stearoyl phytosphingosine 0.1
8). Tocopherol acetate 0.01
9. Cetostearyl alcohol 0.5
10. Behenyl alcohol 0.6
11. Glycerin monooleate 0.4
12 Glycerin monocapric acid ester 0.1
13. Carbomer (Note 3) 0.15
14 (Na-acrylate / acryloyldimethyltaurine Na) copolymer
(Note 4) 0.1
15. Sodium hydroxide 2% solution 0.2
16. Ethanol 5.0
17. Sodium hyaluronate 0.01
18. Hydrolyzed hyaluronic acid 0.01
19. Hydrolyzed collagen 0.01
20. Perfume appropriate amount Note 3: CARBOPOL 980 (manufactured by LUBRIZOL ADVANCED MATERIALS)
Note 4: SIMULGEL EG (manufactured by SEPIC)
(製造方法)
A:成分1〜4を70℃で均一に溶解混合する。
B:成分5〜12を80℃で均一に溶解混合する。
C:AにBを添加し70℃で乳化する。
D:Cに成分13〜20を添加混合した後、40℃まで冷却して水中油型乳化美容液を得た。
(Production method)
A: Components 1 to 4 are uniformly dissolved and mixed at 70 ° C.
B: Components 5 to 12 are uniformly dissolved and mixed at 80 ° C.
C: B is added to A and emulsified at 70 ° C.
D: Components 13 to 20 were added to C and mixed, and then cooled to 40 ° C. to obtain an oil-in-water emulsified cosmetic liquid.
実施例6の水中油型乳化美容液は、肌のハリ・弾力、刺激感、べたつきの全てにおいて優れたものであった。
The oil-in-water emulsified beauty liquid of Example 6 was excellent in all of skin firmness / elasticity, irritation, and stickiness.
本発明は、化粧料、医薬部外品、皮膚外用剤等に適用できる。 The present invention can be applied to cosmetics, quasi drugs, external preparations for skin, and the like.
Claims (6)
(A)ニコチン酸アミド 3〜10質量%
(B)リン脂質 0.1〜5質量%
(C)グリセリンモノ脂肪酸エステル
(D)25℃で液状であり、IOB値が0.10〜0.39である油
(E)水
を含有する、水中油型乳化組成物。
The following components (A) to (D):
(A) Nicotinamide 3 to 10% by mass
(B) Phospholipid 0.1-5 mass%
(C) Glycerin monofatty acid ester (D) An oil-in-water emulsion composition containing oil (E) water that is liquid at 25 ° C. and has an IOB value of 0.10 to 0.39.
The oil-in-water emulsion composition according to claim 1, wherein the content of the component (C) is 0.1 to 5% by mass.
The ratio (A) / ((B) + (C)) of the content mass of the component (A) and the components (B) and (C) in the composition is 0.1-20. An oil-in-water emulsion composition.
The ratio (A) / ((C) + (D)) of the content mass of the component (A) and the components (C) and (D) in the composition is 0.1-20. The oil-in-water emulsion composition described.
The oil-in-water emulsion composition according to claims 1 to 4, wherein the content ratio (C) / (D) of the components (C) and (D) in the composition is 0.01 to 5.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016063476A JP2017178789A (en) | 2016-03-28 | 2016-03-28 | Oil-in-water type emulsified composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016063476A JP2017178789A (en) | 2016-03-28 | 2016-03-28 | Oil-in-water type emulsified composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2017178789A true JP2017178789A (en) | 2017-10-05 |
Family
ID=60009201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016063476A Pending JP2017178789A (en) | 2016-03-28 | 2016-03-28 | Oil-in-water type emulsified composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2017178789A (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019131492A (en) * | 2018-01-30 | 2019-08-08 | 株式会社コーセー | Skin external preparations or cosmetics |
| JP2019131552A (en) * | 2018-01-31 | 2019-08-08 | 株式会社コーセー | Cosmetics or skin external preparations having improved skin permeability of skin active ingredient |
| JP2019131547A (en) * | 2018-01-31 | 2019-08-08 | 株式会社コーセー | Aqueous composition |
| JP2019131507A (en) * | 2018-01-31 | 2019-08-08 | 株式会社コーセー | Skin external preparations or cosmetics |
| WO2020137017A1 (en) * | 2018-12-26 | 2020-07-02 | 日本精化株式会社 | Whitening agent, hyaluronic acid production promoter, collagen production promoter, intracellular active oxygen scavenger, irritation mitigator, wrinkle-ameliorating agent, complex, cosmetic and external preparation for skin |
| JP2020117500A (en) * | 2019-01-22 | 2020-08-06 | ロート製薬株式会社 | External composition for skin |
| JP2020152681A (en) * | 2019-03-20 | 2020-09-24 | 株式会社マンダム | Emulsion cosmetic composition |
| JP2022103138A (en) * | 2020-12-25 | 2022-07-07 | ちふれホールディングス株式会社 | Underwater oil type emulsified cosmetic |
| JP2022130776A (en) * | 2021-02-26 | 2022-09-07 | 株式会社ファンケル | emulsified cosmetic |
-
2016
- 2016-03-28 JP JP2016063476A patent/JP2017178789A/en active Pending
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019131492A (en) * | 2018-01-30 | 2019-08-08 | 株式会社コーセー | Skin external preparations or cosmetics |
| JP7071830B2 (en) | 2018-01-30 | 2022-05-19 | 株式会社コーセー | External skin preparation or cosmetics |
| JP7104643B2 (en) | 2018-01-31 | 2022-07-21 | 株式会社コーセー | Aqueous composition |
| JP2019131552A (en) * | 2018-01-31 | 2019-08-08 | 株式会社コーセー | Cosmetics or skin external preparations having improved skin permeability of skin active ingredient |
| JP2019131547A (en) * | 2018-01-31 | 2019-08-08 | 株式会社コーセー | Aqueous composition |
| JP2019131507A (en) * | 2018-01-31 | 2019-08-08 | 株式会社コーセー | Skin external preparations or cosmetics |
| JP7032945B2 (en) | 2018-01-31 | 2022-03-09 | 株式会社コーセー | External skin preparation or cosmetics |
| JP7364339B2 (en) | 2018-01-31 | 2023-10-18 | 株式会社コーセー | Cosmetics or skin preparations with improved skin permeability of active skin ingredients |
| WO2020137017A1 (en) * | 2018-12-26 | 2020-07-02 | 日本精化株式会社 | Whitening agent, hyaluronic acid production promoter, collagen production promoter, intracellular active oxygen scavenger, irritation mitigator, wrinkle-ameliorating agent, complex, cosmetic and external preparation for skin |
| JP2020117500A (en) * | 2019-01-22 | 2020-08-06 | ロート製薬株式会社 | External composition for skin |
| JP2020152681A (en) * | 2019-03-20 | 2020-09-24 | 株式会社マンダム | Emulsion cosmetic composition |
| JP7309400B2 (en) | 2019-03-20 | 2023-07-18 | 株式会社マンダム | emulsified cosmetic composition |
| JP7159435B2 (en) | 2020-12-25 | 2022-10-24 | ちふれホールディングス株式会社 | Oil-in-water emulsified cosmetic |
| JP2022103138A (en) * | 2020-12-25 | 2022-07-07 | ちふれホールディングス株式会社 | Underwater oil type emulsified cosmetic |
| JP2022130776A (en) * | 2021-02-26 | 2022-09-07 | 株式会社ファンケル | emulsified cosmetic |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017178789A (en) | Oil-in-water type emulsified composition | |
| JP7079827B2 (en) | External skin composition containing an oily moisturizer | |
| JP2022087249A (en) | Oil-in-water emulsion composition | |
| JP6457765B2 (en) | Oil-in-water emulsified cosmetic | |
| CN102388107A (en) | Volatile oily composition | |
| JP2019131492A (en) | Skin external preparations or cosmetics | |
| EA004662B1 (en) | Vesicle forming skin oil containing w/o emulsifiers with a hydrophilic-lipophilic balance of 2-6, method for the production and use thereof | |
| TW201505661A (en) | Oil-in-water emulsion skin cosmetic composition | |
| JP2022075265A (en) | Oil-in-water emulsified composition containing behendimonium ethyl stearyl phosphate | |
| JP6348253B2 (en) | Emulsion composition containing stearyl glycyrrhetinate | |
| JP5069841B2 (en) | Use of plant sterol esters and triterpene alcohol esters obtained from rice bran | |
| JP2008231087A (en) | Skin preparation for external use | |
| TWI694841B (en) | W/O type emulsifier and its premix | |
| JP2023553098A (en) | Cosmetic composition containing sucrose ester and solvent | |
| CA2086689A1 (en) | Cosmetic or dermatological composition containing a diol ester | |
| JP7364339B2 (en) | Cosmetics or skin preparations with improved skin permeability of active skin ingredients | |
| JP6336313B2 (en) | Oil-in-water emulsion composition | |
| JP6266877B2 (en) | Emulsion composition containing stearyl glycyrrhetinate | |
| JP2010270067A (en) | Emulsion composition | |
| JP6918548B2 (en) | Topical skin or cosmetics | |
| KR101815127B1 (en) | Thermo-sensitive color cosmetic composition and the method of producing the same | |
| JP3671103B2 (en) | Cosmetics | |
| JP7032117B2 (en) | Oily composition | |
| US11039991B2 (en) | Hydrophobic gel based on vitamin e free from silicone products for topical application | |
| JP4250501B2 (en) | Gel oily cosmetic |